These results, together with the results shown in Figure 2 and Supplementary Figure S3, demonstrate that the p53LCs can confer the resistance of wt p53-harboring lung cancer cells to the p53-activating agents through their DN effects. This evidence concerns the gene TP53 and lung cancer.